Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Phase of Trial: Phase IV
Latest Information Update: 28 May 2018
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Acronyms UPSTREAM
- Sponsors AstraZeneca
- 21 May 2018 Planned End Date changed from 30 Mar 2018 to 31 Mar 2020.
- 21 May 2018 Planned primary completion date changed from 30 Mar 2018 to 31 Mar 2020.
- 10 Jun 2017 Biomarkers information updated